Ezetimibe Reduces Low-Density Lipoprotein Cholesterol (LDL-C) in Renal Transplant Patients Resistant to HMG-CoA Reductase Inhibitors

2007 ◽  
Vol 14 (5) ◽  
pp. 438-441 ◽  
Author(s):  
Peale Chuang ◽  
Anthony J Langone
1997 ◽  
Vol 133 (1) ◽  
pp. 51-59 ◽  
Author(s):  
Masakazu Sakai ◽  
Shozo Kobori ◽  
Takeshi Matsumura ◽  
Takeshi Biwa ◽  
Yoshihiro Sato ◽  
...  

1991 ◽  
Vol 29 (12) ◽  
pp. 47-48

Last year we reviewed simvastatin,1 which lowers total and low-density-lipoprotein cholesterol (LDL-C) in plasma by competitively inhibiting the rate-limiting enzyme in cholesterol synthesis, HMG CoA reductase, in the liver. Pravastatin (Lipostat – Bristol-Myers Squibb) is a similar drug.


Sign in / Sign up

Export Citation Format

Share Document